Insider Transactions in Q1 2022 at Exagen Inc. (XGN)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2022
|
Fortunato R. Rocca President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,322
-3.46%
|
$30,254
$7.12 P/Share
|
|
Mar 01
2022
|
Kamal Adawi CFO and Corporate Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
3,241
-3.21%
|
$22,687
$7.12 P/Share
|
|
Mar 01
2022
|
Mark Hazeltine Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,241
-3.15%
|
$22,687
$7.12 P/Share
|
|
Mar 01
2022
|
Debra Zack Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,241
-3.7%
|
$22,687
$7.12 P/Share
|
|
Feb 04
2022
|
Fortunato R. Rocca President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+37.5%
|
-
|
|
Feb 04
2022
|
Kamal Adawi CFO and Corporate Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
63,500
+38.6%
|
-
|
|
Feb 04
2022
|
Mark Hazeltine Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
63,500
+38.15%
|
-
|
|
Feb 04
2022
|
Debra Zack Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+36.36%
|
-
|